Skip to main content
. 2022 Jan 6;46(4):677–685. doi: 10.1007/s00264-021-05290-0

Table 3.

Microbiological results (UFC) at the end of the study (4 weeks after the first stage of exchange)

Sample X¯(SD) p
Control Rifampicin
Spacer 1.09·102 (SD 2.19·102) UFC 3.6·102 (SD 7.4·102) UFC 0.71
Bone 5.7·102 (SD 1.2·103) UFC 0 UFC 0.03
Soft tissue 2.3·104 (SD 5.6·104) UFC 0 UFC 0.01